John Higgins Net Worth - Insider Trades and Bio as of Jun 19, 2026

OABIOmniAb, Inc.SEC CIK: 0001208906

Estimated Net Worth

$109 Million

Last Updated: May 19, 2026 11:10 PM EST

Transaction Summary

Total Transactions103

Buy-Sell Ratio0.17

Buy Transactions5

Sell Transactions29

Transaction Volume

Total Volume-$12.69M

Net Volume$13.70M

Buy Volume$505.94K

Sell Volume-$13.19M

Trade Analysis

AVG Trade Size-$98.86K

Largest Trade$2.32M

Most Active MonthMay

Most Active Year2022

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

John L Higgins has an estimated net worth of $109 Million. This is based on reported shares across multiple companies, which include OmniAb, Inc., BIO-TECHNE Corp, LIGAND PHARMACEUTICALS INC, BIOCRYST PHARMACEUTICALS INC, and CONNETICS CORP.

2022 was John L Higgins's most active year for acquiring shares with 27 total transactions. John L Higgins's most active month to acquire stocks was the month of September. 2022 was John L Higgins's most active year for disposing of shares, totalling 23 transactions. John L Higgins's most active month to dispose stocks was the month of July. 2012 saw John L Higgins paying a total of $2,324,837.02 for 186,666 shares, this is the most they've acquired in one year. In 2018 John L Higgins cashed out on 20,000 shares for a total of $1,879,173.00, their largest year based on trade value.

Holdings & Transactions

OABIomniab, inc.

Updated: Jan 30, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Jan 30, 2026	2.96M	Options	—	Jan 30	View
From 4	0.03	77.26K	$1.39	$107.71K	Nov 10, 2025	2.93M	Purchase	—	Nov 06 - 07	View
From 4	0.02	60.00K	—	—	Jun 18, 2025	2.93M	Options	—	Jun 17	View
From 4	0.02	65.00K	$1.44	$93.60K	May 13, 2025	2.83M	Purchase	—	May 12	View
From 4	0.00	4.00K	$2.28	$9.12K	Mar 21, 2025	2.77M	Purchase	—	Mar 21	View
From 4	0.05	125.75K	$2.35	$295.51K	Mar 20, 2025	2.76M	Purchase	—	Mar 20	View
From 4	—	—	—	—	Jan 30, 2025	2.67M	Options	—	Jan 30	View
From 4	0.02	60.00K	—	—	Jun 21, 2024	2.71M	Options	—	Jun 18	View
From 4/A	13.79	2.43M	—	—	Apr 23, 2024	2.60M	Grant	—	Nov 01	View
From 4	—	—	—	—	Jan 31, 2024	2.40M	Options	—	Jan 30	View
From 4	0.06	143.72K	$3.36	$281.55K	Jun 27, 2023	2.48M	Grant	—	Dec 28 - 23	View
From 4	-0.00	9.00K	$3.87	-$3.33K	May 25, 2023	2.46M	Sale	—	May 23	View
From 4	-0.00	1.00K	$3.87	-$370.00	May 23, 2023	2.47M	Sale	—	May 19	View
From 4	-0.02	50.00K	$3.79	-$10.50K	May 19, 2023	2.47M	Sale	—	May 18	View
From 4	0.07	181.54K	—	—	Feb 01, 2023	2.60M	Grant	—	Jan 30	View
From 4	—	4.33M	$2.52	—	Nov 03, 2022	4.33M	Options	—	Nov 01 - 02	View
From 3	—	—	—	—	Nov 03, 2022	—	—	—	—	View

TECHbio-techne corp

Updated: Nov 03, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.08	5.42K	—	—	Nov 03, 2025	134.20K	Grant	—	Oct 30	View
From 4	—	—	$21.84	$110.07K	Aug 11, 2025	128.78K	Options	—	Aug 07	View
From 4	—	—	$21.84	$262.08K	May 05, 2025	128.78K	Options	—	May 01	View
From 4	0.11	4.97K	—	—	Oct 28, 2024	128.78K	Grant	—	Oct 24	View
From 4	-0.04	1.87K	$48.08	$523.20	Sep 16, 2024	123.81K	Options	—	Sep 12	View
From 4	—	—	$22.95	$137.70K	Jul 10, 2024	125.68K	Options	—	Jul 08	View
From 4	-0.08	4.00K	$53.40	-$243.58K	May 16, 2024	125.68K	Sale	—	May 14	View
From 4	0.16	5.56K	—	—	Oct 30, 2023	129.68K	Grant	—	Oct 26	View
From 4	-0.11	4.38K	$50.86	-$34.76	May 02, 2023	124.12K	Options	—	Apr 28	View
From 4	0.22	1.20K	—	—	Oct 31, 2022	32.12K	Grant	—	Oct 27	View
From 4	-0.31	2.50K	$222.85	-$721.06K	Aug 12, 2022	30.92K	Sale	—	Aug 10 - 11	View
From 4	-0.17	1.60K	$215.94	-$476.92K	Jun 09, 2022	33.43K	Sale	—	Jun 07 - 08	View
From 4	0.19	827.00	—	—	Nov 01, 2021	35.03K	Grant	—	Oct 28	View
From 4	-0.53	5.00K	$185.35	-$1.15M	Nov 10, 2020	32.69K	Sale	—	Nov 06	View
From 4	0.47	1.90K	—	—	Nov 02, 2020	39.20K	Grant	—	Oct 29	View
From 4	-0.55	5.00K	$133.35	-$718.83K	Feb 14, 2020	37.30K	Sale	—	Feb 12	View
From 4	0.71	2.51K	—	—	Oct 28, 2019	47.30K	Grant	—	Oct 24	View
From 4	-0.59	5.00K	$133.35	-$703.20K	Jun 06, 2019	49.79K	Sale	—	Jun 04	View
From 4	0.80	2.41K	—	—	Oct 29, 2018	54.79K	Grant	—	Oct 25	View
From 4	-0.77	10.00K	$124.50	-$1.27M	Aug 27, 2018	42.38K	Sale	—	Aug 23	View
From 4	1.70	3.86K	—	—	Oct 30, 2017	52.38K	Grant	—	Oct 26	View
From 4	3.60	4.90K	—	—	Oct 31, 2016	48.52K	Grant	—	Oct 27	View
From 4	-0.56	1.70K	$109.83	-$186.72K	Sep 12, 2016	43.62K	Sale	—	Sep 08	View
From 4	2.66	5.32K	—	—	Nov 02, 2015	45.32K	Grant	—	Oct 29	View
From 4	5.00	5.00K	—	—	Nov 03, 2014	40.00K	Grant	—	Oct 30	View
From 4	—	5.00K	—	—	Nov 04, 2013	35.00K	Grant	—	Oct 31	View
From 4	—	5.00K	—	—	Oct 26, 2012	30.00K	Grant	—	Oct 25	View
From 4	—	5.00K	—	—	Oct 28, 2011	25.00K	Grant	—	Oct 27	View
From 4	—	5.00K	—	—	Oct 29, 2010	20.00K	Grant	—	Oct 28	View
From 4	—	5.00K	—	—	Oct 30, 2009	15.00K	Grant	—	Oct 29	View
From 4	—	10.00K	—	—	May 20, 2009	10.00K	Grant	—	May 19	View
From 3	—	—	—	—	May 20, 2009	—	—	—	—	View

LGNDligand pharmaceuticals inc

Updated: Dec 30, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.01	5.29K	$66.29	-$350.61K	Dec 30, 2022	417.70K	Tax	—	Dec 28	View
From 4	—	92.93K	—	—	Dec 27, 2022	92.93K	Grant	—	Dec 22	View
From 4	-0.02	10.00K	$61.87	-$618.66K	Dec 20, 2022	422.98K	Sale	Scheduled	Dec 16	View
From 4	-0.01	3.94K	$38.79	$28.80	Dec 14, 2022	453.32K	Options	—	Dec 12	View
From 4	-0.02	9.80K	$72.90	-$714.64K	Dec 01, 2022	416.93K	Tax	—	Nov 30	View
From 4	-0.02	10.00K	$45.55	-$655.37K	Nov 21, 2022	467.07K	Sale	Scheduled	Nov 17 - 18	View
From 4/A	—	—	—	—	Nov 07, 2022	426.73K	—	—	—	View
From 4	0.12	45.92K	—	—	Nov 03, 2022	424.73K	Grant	—	Nov 01	View
From 4/A	-0.00	1.00K	$88.06	-$88.06K	Sep 22, 2022	366.18K	Sale	—	Sep 16	View
From 4	-0.01	5.00K	$89.61	-$448.05K	Sep 16, 2022	364.18K	Sale	—	Sep 15 - 16	View
From 4	0.00	164.00	$75.84	$12.44K	Jul 06, 2022	369.18K	Acquisition	—	Jun 30	View
From 4	0.06	20.42K	—	—	Jun 14, 2022	369.02K	Grant	—	Jun 10	View
From 4	—	—	$21.92	$175.36K	May 10, 2022	406.21K	Sale	—	May 09 - 10	View
From 4	—	76.48K	—	—	May 09, 2022	76.48K	Grant	—	May 05	View
From 4/A	—	—	—	—	Sep 24, 2019	—	Purchase	—	Sep 19	View
From 4/A	1.87	166.67K	$14.47	$2.32M	Jun 04, 2013	255.94K	Grant	—	Feb 09	View
From 3	—	—	—	—	Jan 25, 2007	—	—	—	—	View

BCRXbiocryst pharmaceuticals inc

Updated: May 25, 2012VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	15.00K	—	—	May 25, 2012	15.00K	Grant	—	May 23	View
From 4	—	15.00K	—	—	May 16, 2011	15.00K	Grant	—	May 12	View
From 4	—	15.00K	—	—	May 17, 2010	15.00K	Grant	—	May 13	View
From 4	—	15.00K	$3.96	$59.40K	Jun 01, 2009	90.00K	Grant	—	Apr 30	View
From 4	—	15.00K	$3.12	$46.80K	May 23, 2008	15.00K	Grant	—	May 21	View
From 4	—	15.00K	$7.98	$119.70K	May 17, 2007	15.00K	Grant	—	May 16	View
From 4	—	15.00K	$12.26	$183.90K	May 18, 2006	15.00K	Grant	—	May 17	View
From 4	1.00	10.00K	$4.30	$43.00K	May 13, 2005	20.00K	Grant	—	May 11	View
From 3/A	—	—	—	—	May 18, 2004	—	—	—	—	View
From 4	—	10.00K	$8.83	$88.30K	May 14, 2004	10.00K	Grant	—	May 12	View
From 3	—	—	—	—	May 14, 2004	—	—	—	—	View

connetics corp

EVP, Finance, Corp Dev. & CFO Officer

Updated: Jan 03, 2007

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	428.30K	$13.72	-$4.50M	Jan 03, 2007	—	Disposition	—	Dec 28 - 29	View
From 4	-0.05	6.00K	—	—	Dec 21, 2006	114.12K	Grant	—	Dec 21	View
From 4	0.82	60.86K	—	$60.86	Feb 03, 2006	135.12K	Grant	—	Feb 01	View
From 4	—	—	$12.37	-$73.58K	Sep 02, 2005	1.05M	Options	—	Sep 02	View
From 4	-0.01	15.00K	$14.31	-$471.18K	Aug 24, 2005	1.55M	Sale	Scheduled	Aug 22	View
From 4	-0.13	10.00K	$20.71	-$207.07K	Jun 14, 2005	68.45K	Sale	Scheduled	Jun 10	View
From 4	-0.01	1.15K	$18.40	-$21.24K	Jun 02, 2005	78.45K	Disposition	—	May 31	View
From 4	-0.01	5.00K	$22.57	-$273.75K	Apr 21, 2005	583.03K	Sale	Scheduled	Apr 19	View
From 4	-0.01	4.00K	$21.78	-$210.60K	Mar 15, 2005	588.03K	Sale	Scheduled	Mar 15	View
From 4	0.09	81.00K	$23.35	$1.89M	Jan 19, 2005	1.02M	Grant	—	Jan 18	View
From 4	-0.02	12.50K	$17.89	-$528.37K	Jan 18, 2005	600.83K	Sale	Scheduled	Jan 14	View
From 4	0.01	881.00	$10.30	$9.08K	Dec 02, 2004	77.30K	Acquisition	—	Nov 30	View
From 4	-0.00	5.00K	$23.13	-$268.57K	Nov 12, 2004	1.66M	Sale	Scheduled	Nov 10	View
From 4	-0.09	7.50K	$26.62	-$199.66K	Nov 02, 2004	76.67K	Sale	Scheduled	Nov 01	View
From 4	-0.02	34.55K	$21.64	-$2.02M	Aug 03, 2004	1.95M	Sale	Scheduled	Jul 30 - 02	View
From 4	-0.12	10.00K	$20.77	-$207.74K	Jun 17, 2004	73.72K	Sale	Scheduled	Jun 15	View
From 4	0.03	2.27K	$10.30	$23.44K	Jun 01, 2004	83.72K	Acquisition	—	May 28	View
From 4	-0.01	5.00K	$18.96	-$179.89K	Mar 16, 2004	577.68K	Sale	Scheduled	Mar 12	View
From 4	0.05	48.10K	$17.11	$573.64K	Feb 23, 2004	1.09M	Options	—	Feb 20	View
From 4	-0.02	15.00K	$21.09	-$624.69K	Feb 11, 2004	588.49K	Sale	Scheduled	Feb 09	View
From 4	-0.05	25.00K	$17.29	-$697.71K	Jan 22, 2004	498.49K	Sale	Scheduled	Jan 20 - 21	View
From 4	0.24	90.00K	$18.05	$1.62M	Jan 05, 2004	463.19K	Grant	—	Jan 02	View
From 4	-0.04	2.18K	$10.30	-$22.50K	Dec 01, 2003	60.30K	Disposition	—	Nov 28	View
From 4	-0.15	10.00K	$19.00	-$190.00K	Oct 15, 2003	58.11K	Sale	Scheduled	Oct 14	View
From 4	0.08	38.38K	$14.82	$398.46K	Sep 05, 2003	531.30K	Options	—	Sep 03	View
From 4	—	—	—	—	Jun 03, 2003	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions